Investor Communications
NorthStar Healthcare’s Q2 2024 Results and Business Update Conference Call
Click here for replay
Investor Presentation - Internalization of Management
Investor Presentation NHI Internalization, October 2022
Frequently Asked Questions
Updated November 14, 2023
Click here to download the Frequently Asked Questions PDF
Supplemental Financial Reports
Second Quarter Ended 2024 Financial Supplement– 8.12.2024
First Quarter Ended 2024 Financial Supplement – 5.09.2024
Year Ended 2023 Financial Supplement – 3.22.2024
Third Quarter 2023 Financial Supplement and Estimated Net Asset Value – 11.14.2023
Second Quarter 2023 Financial Supplement – 08.14.2023
First Quarter 2023 Financial Supplement – 05.10.2023
Click here for previous Supplemental Financial Reports
Shareholder Letters
Response to West 4 Tender Offer – 08.12.2024
Response to Comrit Tender Offer – 05.01.2024
Response to Comrit Tender Offer – 01.11.2024
June 30, 2023 Estimated Per Share Value – 11.14.2023
Response to Comrit Tender Offer – 03.10.2023
June 30, 2022 Estimated Per Share Value – 11.17.2022
Response to Comrit Tender Offer – 12.7.2022
Suspension of the Distribution Reinvestment Plan - 4.12.2022
June 30, 2021 Estimated Per Share Value – 11.18.2021
Response to Comrit Tender Offer - 4.27.2021
June 30, 2020 Estimated Per Share Value - 12.21.2020
Response to Comrit Tender Offer - 12.4.2020
Share Repurchase Program Suspension - 4.14.2020
June 30, 2019 Estimated Per Share Value - 12.11.2019
Response to Comrit Tender Offer - 12.11.2019
Monthly Distribution Suspension - 2.7.2019
Amended Share Repurchase Program - 10.15.2018
Response to MacKenzie Tender Offer - 8.13.2018